Objective: Little has been published regarding treatment guidelines for tin
ea gladiatorum in the competitive wresting population, where outbreaks are
commonplace. This study compares the efficacy of a first-line topical treat
ment regimen and an oral treatment regimen.
Design: A randomized, prospective, open-label pilot study was conducted dur
ing the 1997 to 1998 interscholastic wrestling season.
Setting: Training rooms at two suburban high schools.
Participants: Male high school wrestlers with culture-proven tinea corporis
were included in the study. There were 22 wrestlers enrolled: 17 finished
the study.
Interventions: Wrestlers were randomized to receive either clotrimazole 1%
cream applied twice daily or fluconazole 200 mg once weekly for a total tre
atment duration of 3 weeks.
Main Outcome Measures: Symptom scores, lesion measurements, and fungal cult
ures were followed to assess treatment efficacy.
Results: Eleven wrestlers received clotrimazole and six wrestlers finished
the full course of fluconazole. The extrapolated time to 50% improvement in
symptom scores was 11.9 days in the clotrimazole group and 10.1 days in th
e fluconazole group. The extrapolated time to 50% lesion reduction was 18.7
days in the clotrimazole group and 17.2 days in the fluconazole group. The
extrapolated time to 50% culture eradication was 22.7 days in the clotrima
zole group and 11.1 days in the flu conazole group.
Conclusion: Both clotrimazole and fluconazole produce similar improvement i
n clinical parameters. Fluconazole showed arithmetically, but not statistic
ally, superior culture eradication. Fluconazole in a weekly dosing schedule
should be considered in the first-line treatment of tinea gladiatorum.